EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Stock News

TSX-V:EVMT - TSX Venture Exchange - CA30053H1055 - Common Stock - Currency: CAD

0.005 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

EVMT.CA Latest News, Press Relases and Analysis

All

Press Releases

3 months ago - By: Evome Medical Technologies Inc.

News Image

Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies

4 months ago - By: Evome Medical Technologies Inc.

Evome Medical Technologies Provides Market Update

4 months ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Technologies Appoints Michael Dalsin as Chairman of the Board of Directors; Increases Size of Board to Six

5 months ago - By: Evome Medical Technologies Inc.

News Image

CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring

5 months ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Technologies Announces Significant Debt Reduction and Restructuring

6 months ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Technologies Grants Restricted Stock Units to New Chief Operating Officer

8 months ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt

a year ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan

a year ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Technologies Reports Second Quarter 2024 Financial Results

a year ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Technologies Retains irlabs for Investor Relations Services

8 months ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders

a year ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Technologies Announces Securities Issuances

a year ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2

a year ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt

a year ago - By: Evome Medical Technologies Inc.

News Image

Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled

a year ago - By: Evome Medical Technologies Inc.

News Image

Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt

a year ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Engages ICP Securities Inc. for Automated Market Making Services

a year ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023

a year ago - By: Evome Medical Technologies Inc.

News Image

Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman

a year ago - By: Evome Medical Technologies Inc. - Mentions: SGMD.CA

News Image

Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024

a year ago - By: Evome Medical Technologies Inc. - Mentions: SGMD.CA

News Image

Evome Medical Technologies Reduces Acquisition Debt, Bolsters Management Team to Support SpaceTeck Knee™ and Reactive Step Trainer 2024 Product Roll-Out